Welcome to Novo Nordisk in the United States

file

About the author:

Todd Hobbs, MD, is vice president and chief medical officer for Novo Nordisk in North America, where he leads the organization’s focus on the implications of diabetes for the patient, healthcare system and healthcare professionals.

Entries by Todd Hobbs

    Keeping the dreamers dreaming

    30 October 2017

    We can never lose faith in the “Eureka” moments that bring innovation to life. Yes, as a science-driven company, we’re placing bets on medicines most likely to demonstrate meaningful efficacy benefits and acceptable safety profiles in rigorous clinical trials. But even after serving people with diabetes for almost a century, we have to appreciate that the next breakthroughs against this serious disease may come from a new researcher who believes pushing boundaries is the starting point and nothing extraordinary.

     
    Read more

    Perspectives from Todd Hobbs, MD

    07 June 2017

    Our Chief Medical Officer has diabetes and a child with diabetes. 

    We talk with Todd Hobbs, vice president and chief medical officer for Novo Nordisk in North America. Todd brings a unique perspective to his job title – he was diagnosed with type 1 diabetes nearly 30 years ago and one of his sons has been a type 1 since the age of 5.

    In this first of a series of posts with Dr. Hobbs, he digs into what he believes innovation in diabetes means. 

    Read more